This edition of the Private Company Report highlights critical developments and regulatory changes affecting private companies, including recent presidential actions, SEC guidance on Regulation D and amendments to the Delaware General Corporation Law (DGCL). We also provide updates on the IPO market, developments in the biotech industry, and Foreign Corrupt Practices Act (FCPA) and antitrust enforcement. Staying informed on these topics is important for a private company’s effective compliance and strategic planning.
Please see full publication below for more information.
